MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1089/thy.2023.0317

Медицинская библиотека · Thyroid : official journal of the American Thyroid Association · 2023

The Effect of Vitamin D Supplementation on Hypothyroidism in the Randomized Controlled D-Health Trial.

Waterhouse Mary, Pham Hai, Rahman Sabbir T, Baxter Catherine, Duarte Romero Briony, Armstrong Bruce K, Ebeling Peter R, English Dallas R, Hartel Gunter, van der Pols Jolieke C, Venn Alison J, Webb Penelope M, Whiteman David C, McLeod Donald S A, Neale Rachel E

СтатьяПеревод пока не подготовлен

Аннотация

Background

Hypothyroidism is common, and in iodine-sufficient areas, it is primarily caused by autoimmune destruction of the thyroid gland. Observational studies have consistently shown an inverse association between serum 25-hydroxyvitamin D concentration and autoimmune diseases; however, there is a lack of evidence from randomized controlled trials to support a benefit of vitamin D supplementation, particularly for autoimmune thyroid diseases. We, therefore, aimed to assess the effect of vitamin D supplementation on the incidence of hypothyroidism.

Methods

We analyzed data from the D-Health Trial (n = 21,315), a randomized double-blind placebo-controlled trial of 60,000 international units per month of supplemental vitamin D3 among Australians aged 60 years and over. Hypothyroidism, a tertiary outcome of the D-Health Trial, was defined by treatment with levothyroxine, ascertained through linkage with the Australian Pharmaceutical Benefits Scheme. The outcome was time to first prescription of levothyroxine. We began follow-up at 12 months after randomization; people who had died or who had been dispensed levothyroxine during the first year were excluded. Flexible parametric survival models were used to assess the effect of vitamin D supplementation on hypothyroidism, overall and within strata defined by age, sex, body mass index, and predicted baseline vitamin D status.

Results

We included 17,851 participants in the main analysis (vitamin D = 8939; placebo = 8912). During a median follow-up of 4.1 years (interquartile range 4.1-4.1), 293 participants developed hypothyroidism (vitamin D = 138 [1.5%]; placebo = 155 [1.7%]). Vitamin D supplementation did not significantly reduce the incidence of hypothyroidism (overall hazard ratio [HR] 0.89; 95% confidence interval [CI] 0.71-1.12). There was some suggestion of an effect in females (overall HR 0.78; CI 0.58-1.06) but not in males (overall HR 1.06; CI 0.74-1.50; p interaction 0.20).

Conclusions

Vitamin D supplementation did not reduce the incidence of hypothyroidism overall; however, the possible beneficial effect observed in females warrants further investigation. Clinical Trial Registration: Australian New Zealand Clinical Trials Registry: ACTRN12613000743763.

Для цитирования: Waterhouse Mary, Pham Hai, Rahman Sabbir T, Baxter Catherine, Duarte Romero Briony, Armstrong Bruce K, Ebeling Peter R, English Dallas R, Hartel Gunter, van der Pols Jolieke C, Venn Alison J, Webb Penelope M, Whiteman David C, McLeod Donald S A, Neale Rachel E. The Effect of Vitamin D Supplementation on Hypothyroidism in the Randomized Controlled D-Health Trial.. Thyroid : official journal of the American Thyroid Association. 2023. DOI: 10.1089/thy.2023.0317.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.